Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.42−0.06 (-4.05%)
Close on Nov 17, 2026Market cap $53.14MP/E –Yield –
Tenax Therapeutics EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Tenax Therapeutics's EV/EBITDA was 68.9× on Jan 31, 2024.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 68.9× | −48.5 |
| 2023 | Dec 29, 2023 | 117.3× | −692.5 |
| 2022 | Jan 31, 2022 | 809.8× | – |
See a number that looks wrong?